"Hepatitis B e Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.
| Descriptor ID |
D006513
|
| MeSH Number(s) |
D23.050.327.495.500.469
|
| Concept/Terms |
Hepatitis B e Antigens- Hepatitis B e Antigens
- Hepatitis Be Antigens
- Antigens, Hepatitis Be
- Be Antigens, Hepatitis
- e Antigens
- Antigens, e
- HBeAg
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B e Antigens".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B e Antigens".
This graph shows the total number of publications written about "Hepatitis B e Antigens" by people in this website by year, and whether "Hepatitis B e Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B e Antigens" by people in Profiles.
-
Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen HLA, Pan CQ, ?elen MK, Furusyo N, Shalimar D, Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani Subramanian G, Gane EJ, Buti M, Chan HLY. 96?weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. J Hepatol. 2018 04; 68(4):672-681.
-
Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, Kamangar F. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial. Am J Gastroenterol. 2005 Apr; 100(4):856-61.